Bumper Offer - Urjas oil Just @ Rs. 1
Sugatrol is a commercial drug that is prescribed in the form of Tablet. Other than this, Sugatrol has some other therapeutic uses, which have been discussed ahead.
The right dosage of Sugatrol depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Sugatrol also has some side effects, the most common being Stomach Upset, Difficulty urinating. Besides the aforementioned side effects, there are other adverse effects of Sugatrol as well, which are listed below. Normally, these side effects of Sugatrol are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Sugatrol's effect during pregnancy is Mild and Moderate while nursing. Further, the section on Sugatrol related warnings talks about Sugatrol's effects on the liver, heart and kidney.
Sugatrol can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Sugatrol in conditions like Liver Disease, Kidney Disease, Heart Disease. Other conditions have been mentioned below in the Sugatrol contraindications section.
Drug reaction of Sugatrol with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Sugatrol, it is important to know that it is safe while driving, and is habit-forming.
Sugatrol is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Sugatrol is used -
Severe
Moderate
Mild
Common
Is the use of Sugatrol safe for pregnant women?
Pregnant women can consume [medicine]. Though Sugatrol has mild side effects when taken during pregnany
Is the use of Sugatrol safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Sugatrol. Immediately discontinue Sugatrol if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Sugatrol on the Kidneys?
Sugatrol is completely safe for kidneys.
What is the effect of Sugatrol on the Liver?
There are no any side effects of Sugatrol on the liver.
What is the effect of Sugatrol on the Heart?
There are no any side effects of Sugatrol for the heart.
Sugatrol should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Sugatrol unless your doctor advises you to do so -
Is this Sugatrol habit forming or addictive?
Sugatrol does not cause addiction.
Interaction between Food and Sugatrol
Information is not available on the interaction of any foods with Sugatrol, due to a lack of research on this.
Interaction between Alcohol and Sugatrol
Taking Sugatrol with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glynase® PresTab® (micronized glyburide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826